跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Approved
STANDARD
APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e9566d7e8bfdb74d
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
e9566d7e8bfdb74d
Product Name
APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id
210565
Artg Name
APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2013-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01425-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01424-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e9566d7e8bfdb74d
Type
Standard
Back to TGA Approvals